SBCVC logo

SBCVC

Asia, Shanghai, China, Shanghai

Description

SBCVC is a venture capital and private equity firm that manages both USD and RMB funds.

Investor Profile

SBCVC has made 29 investments, with 1 in the past 12 months and 21% as lead.

Stage Focus

  • Series C (21%)
  • Series B (21%)
  • Series A (17%)
  • Series Unknown (17%)
  • Seed (10%)
  • Series E (7%)
  • Private Equity (3%)
  • Angel (3%)

Country Focus

  • China (72%)
  • United States (17%)
  • Australia (7%)
  • Hong Kong (3%)

Industry Focus

  • Software
  • Health Care
  • Information Technology
  • Biotechnology
  • Medical
  • Cloud Computing
  • Biopharma
  • E-commerce
  • Marketing
  • Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SBCVC frequently co-invest with?

IDG Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
GSR Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Cowin Venture
Asia, Beijing, China, Beijing
Co-Investments: 2
Legend Capital
Asia, Beijing, China, Beijing
Co-Investments: 2
Yimei Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 3
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
Tiger Global Management
North America, New York, United States, New York
Co-Investments: 2
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 2
Intel Capital
North America, California, United States, Santa Clara
Co-Investments: 3

Which angels does SBCVC often collaborate with?

DO
North America, United States
Shared Deals: 1
GM
North America, California, United States, Beverly Hills
Shared Deals: 1
PC
North America, California, United States, Redwood City
Shared Deals: 1
MK
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by SBCVC?

UCaize

Shanghai, Shanghai, China

UCaize is a biopharmaceutical developer that is engaged in the research and development of new drugs for the treatment of blood tumors.

BiopharmaHealth CareMedical
SeedFeb 26, 2025
Amount Raised: $11,019,284
TUNGEE

Guangzhou, Guangdong, China

Tungee is a professional sales intelligence solution provider.

Artificial Intelligence (AI)Machine LearningSalesService IndustrySoftware
Series BDec 15, 2021
Amount Raised: $47,113,512
Feiliu

Shanghai, Shanghai, China

Feiliu is a provider of enterprise supply chain management and optimization technology based on artificial intelligence.

Artificial Intelligence (AI)Information TechnologyLogisticsSoftwareSupply Chain Management
Series AMay 31, 2021
Amount Raised: $31,397,174
EDDA Technology

Princeton, New Jersey, United States

EDDA Technology offers computer assistance to the patient care management cycle and enables early detection and diagnosis of diseases.

3D TechnologyHealth CareHealth DiagnosticsInformation Technology
Private EquityApr 7, 2021
Amount Raised: $150,000,000
Corigine

Santa Clara, California, United States

Corigine delivers innovative solutions in connectivity, storage, and machine learning for cloud, automotive, and emerging applications.

Cloud ManagementMachine LearningSemiconductor
SeedMar 22, 2021
Amount Raised: $10,000,000
Tezign

Shanghai, Shanghai, China

Tezign is the contech startup in China aiming to build the digital infrastructure of content experience

AnimationContent MarketingGraphic DesignMarketingSaaSSoftware
Series CMar 18, 2021
Huilianyi

Putuo, Shanghai, China

Huilianyi is a business travel and expense reimbursement system developer based in China.

Travel
Series CMar 30, 2020
Amount Raised: $42,251,736
Taimei Technology

Jiaxing, Zhejiang, China

Taimei Technology provides a cloud platform for clinical research collaboration.

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware
Series EOct 18, 2019
Amount Raised: $211,813,548
New Horizon Health

Hangzhou, Zhejiang, China

New Horizon Health is a bio-tech company focusing on early screening and genetic testing services for high-incidence cancer homes.

Big DataBiotechnologyHealth CareMedical
Series CMay 24, 2019
Amount Raised: $66,500,000
Taimei Technology

Jiaxing, Zhejiang, China

Taimei Technology provides a cloud platform for clinical research collaboration.

BiopharmaBiotechnologyClinical TrialsCloud ComputingMedicalPharmaceuticalSoftware
Series EJan 28, 2019
Amount Raised: $80,000,000